A clinical trial to study the effect of anutaila instillation in nose and azelastine nasal spray in management of allergic rhinitis.

Phase 1/2

Not yet recruiting

• Conditions: Acute nasopharyngitis [common cold]. Ayurveda Condition: PRATISYAYAH/PINASAH,

• Registration Number: CTRI/2023/10/059139
• Lead Sponsor: PDEAs College Of Ayurved And Research Centre

Brief Summary

The study will be intervened by the treatment of Anutaila nasya and Azelastine nasal spray to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective criteria for statistical analysis. Scoring will be designed according to the severity of the symptoms. The subjective gradation of symptoms will be done as folllows and the intensity of each symptom will be calculated before treatment after treatment and after follow up. The signs and symptoms will be assessed by proper scoring method.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-10-11
• Last Update Posted: 2023-10-25

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

• Patients diagnosed with Vataj Pratishyaya showing minimum three sign and syptoms like Nasastrav, Kshvathu, Nasaavrodh, Pihit nasa and Shirshool.
• Age from 18 to 60 will be selected irrespective of sex, socioeconomic status and religion.
• Patient Arah for nasya Patients ready to give written consent for trial and take part in the process of research.

Exclusion Criteria

• Patients with vasomotor rhinitis, acute infective rhinitis, atrophic rhinitis, rhinitis sicca, hypertrophic rhinitis.
• Patients having severe systemic illness Patients who require surgical interventions Patients not willing for clinical trial Patients having associated illness Bronchial Asthma.
• Patient Anarah for Nasya.
• Patients having complaints of complete or bilateral nasal obstruction.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sample Size 56 Decrease in sneezing,nasal obstruction, watery rhinorrhea and headache.	Sample Size 56 Decrease in sneezing,nasal obstruction, watery rhinorrhea and headache in 2 weeks.

Secondary Outcome Measures

Name	Time	Method
Decrease in sneezing,nasal obstruction, watery rhinorrhea and headache.	3 months

Trial Locations

Locations (1)

PDEAs Ayurveda Rugnalaya and Sterling Multispeciality hospital ARSMH; 🇮🇳 Pune, MAHARASHTRA, India

PDEAs Ayurveda Rugnalaya and Sterling Multispeciality hospital ARSMH

🇮🇳Pune, MAHARASHTRA, India

Dr Somesh Kishor Kawade

Principal investigator

7276757957

someshkawade72@gmail.com